Vasuda Capital Management announces 17.6% monthly return in August outperforming major indices
NEWBURYPORT, Mass. - Sept. 2, 2014 - PRLog -- Vasuda Capital Management, LLC, a Greater Boston-based investment firm, announced that its funds and managed accounts outperformed the S&P 500 index in August 2014 (up 17.6% vs. 3.7%). The firm's accounts also out-performed the ishares NASDAQ biotechnology index by 7.35% for the month.
Vasuda Capital Management operates Vasuda Life Sciences Fund, a hedge fund focused on life sciences industry (biotech, pharma, medical devices). The firm's funds have outperformed the S&P 500 in each of last 4 months since inception (up 29%). The firm was founded by Dr. Bhavneesh Sharma, MD, MBA, who is a physician with an MBA in finance and financial markets from the New York University Stern School of Business.
"The biotech industry will see a game-changing transformation in the next 10 years with advances in genomic, regenerative and personalized medicine. The industry is changing the established treatments in areas like immuno-oncology, chronic hepatitis C and fibrotic diseases", said Dr. Sharma. The fund is accepting new investors.
Page Updated Last on: Sep 02, 2014